Amarin to Participate in a Fireside Chat at Citi’s 14th Annual Biotech Conference Read more about Amarin to Participate in a Fireside Chat at Citi’s 14th Annual Biotech Conference
Amarin Announces FDA Notification of Advisory Committee Meeting Planned to be Held in November 2019 in Connection With Vascepa® REDUCE-IT™ sNDA Read more about Amarin Announces FDA Notification of Advisory Committee Meeting Planned to be Held in November 2019 in Connection With Vascepa® REDUCE-IT™ sNDA
Amarin Reports Second Quarter 2019 Financial Results and Operational Update Read more about Amarin Reports Second Quarter 2019 Financial Results and Operational Update
Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares Read more about Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares
Amarin to Report Second Quarter 2019 Results and Host Conference Call on July 31, 2019 Read more about Amarin to Report Second Quarter 2019 Results and Host Conference Call on July 31, 2019
Amarin Prices Public Offering of American Depositary Shares Read more about Amarin Prices Public Offering of American Depositary Shares
Amarin Announces $400,000,000 Public Offering of American Depositary Shares Read more about Amarin Announces $400,000,000 Public Offering of American Depositary Shares
Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance Read more about Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance
Amarin’s John Thero Awarded NJ EY Entrepreneur of The Year® 2019 Award for Life Sciences Read more about Amarin’s John Thero Awarded NJ EY Entrepreneur of The Year® 2019 Award for Life Sciences